HomeBGLC • NASDAQ
add
BioNexus Gene Lab Corp
Previous close
$2.67
Day range
$2.59 - $2.90
Year range
$2.01 - $8.40
Market cap
5.01M USD
Avg Volume
1.25M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.52M | 11.03% |
Operating expense | 985.46K | 117.66% |
Net income | -348.32K | -212.92% |
Net profit margin | -13.80 | -201.69% |
Earnings per share | — | — |
EBITDA | -646.68K | -289.37% |
Effective tax rate | 17.47% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.38M | -26.17% |
Total assets | 10.43M | -8.47% |
Total liabilities | 2.11M | 21.19% |
Total equity | 8.32M | — |
Shares outstanding | 1.80M | — |
Price to book | 0.58 | — |
Return on assets | -15.78% | — |
Return on capital | -18.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -348.32K | -212.92% |
Cash from operations | -69.77K | 91.08% |
Cash from investing | 494.16K | 134.67% |
Cash from financing | 146.59K | -72.43% |
Net change in cash | 161.37K | 109.91% |
Free cash flow | -143.84K | 79.84% |
About
Founded
2017
Website
Employees
30
